Revvity Inc.
USUSDRevvity Inc. (LSE:0KHE) — Biotechnology: Laboratory Analytical Instruments. Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 3. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.
Apie Įmonę
- Svetainė
- revvity.com
- Sektorius
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Būstinė
- Waltham, United States
- Generalinis Direktorius
- Prahlad R. Singh
- Darbuotojai
- 11 000
- Apyvartoje Esančios Akcijos
- 111.59 mln. 2026-08-06 duomenimis
- Laisvai Apyvartinės Akcijos
- 102.49 mln.
- Rinkos Kapitalizacija
- 16.63 mlrd. USD
- Insaideriai
- 0.26%
- Instituciniai Investuotojai
- 96.55%
- Šaka (SIC)
- Laboratory Analytical Instruments
- Teisinė Forma
- ZJTK
- LEI
- 549300IKL1SDPFI7N655
- Išmokų Santykis
- 13.4%
- FCF
- 558 mln. USD6%
- Skola
- 3.21 mlrd. USD3.9 m. FCF
- Dividendų Stažas
- 43 m.
- Pelnas, FCF ir dividendai – už 12 mėnesių iki 05.07.2026 (naujausia įmonės ataskaita).
Aprašymas
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dividendai
Revvity Inc. (RVTY) moka dividendus kas ketvirtį. Per metus (12 mėnesių iki ir įskaitant naujausią paskelbtą mokėjimą): 0.28 USD už akciją (mokėjimai: 4). Tai sudaro apie 0.18% dabartinės akcijų kainos. Kita ex-dividendų data yra 23.10.2026: 0.07 USD už akciją, išmokėjimas 13.11.2026. Nepertraukiamų dividendų metai: 43.
| Ex Data | Išmoka | Suma | % | Tipas | Tikeris |
|---|---|---|---|---|---|
| 2026-10-23 paskelbta | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | kas ketvirtį | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.0/0.2 % | kas ketvirtį | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.0/0.2 % | kas ketvirtį | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.0/0.2 % | kas ketvirtį | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.0/0.2 % | kas ketvirtį | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.0/0.2 % | kas ketvirtį | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.0/0.2 % | kas ketvirtį | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.0/≈0.2 % | kas ketvirtį | US:RVTY |
| 2024-10-18 | 2024-11-08 | 0.0700 USD | 0.0/≈0.2 % | kas ketvirtį | US:RVTY |
| 2024-07-19 | 2024-08-09 | 0.0700 USD | 0.0/≈0.2 % | kas ketvirtį | US:RVTY |
Šios Savaitės Naujienos
Pranešimai spaudai iš įmonės investuotojų svetainės, atnaujinami kasdien. Nuorodos veda į įmonės svetainę. Antraštės pateikiamos originalo kalba, kaip įmonės svetainėje.
| 06.10.2026 | Revvity to Host Investor Day |
Didžiausi Akcininkai
| Turėtojas | Dalis | Akcijos | Ataskaitos Data |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 mln. | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 mln. | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 mln. | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 mln. | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 mln. | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 mln. | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 mln. | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 mln. | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 mln. | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 mln. | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 mln. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 mln. | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 mln. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 mln. | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 mln. | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 mln. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 mln. | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 mln. | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 mln. | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 mln. | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 mln. | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
